⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

October 23, 2024The Lancet Diabetes & EndocrinologyOpen Access

Younger-onset compared with later-onset type 2 diabetes: an analysis of the UK Prospective Diabetes Study (UKPDS) with up to 30 years of follow-up (UKPDS 92)

Beryl Lin Ruth L. Coleman Fiona Bragg Ernesto Maddaloni Rury R. Holman Amanda Adler

View Full Paper

Ask AI

Bookmark

Share

No abstract yet

We only have this paper's title and publication details.

Read it at the source→

Abstract

National Institute of Health and Care Research's Biomedical Research Centre.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Lin et al. (2024) studied this question.

synapsesocial.com/papers/69d72a68a98988943d563c50 https://doi.org/10.1016/s2213-8587(24)00242-0

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1The incidence of type 2 diabetes in the United Kingdom from 1991 to 2010Registry Study · 2013 · 123 citations
2Examining trends in type 2 diabetes incidence, prevalence and mortality in the <scp>UK</scp> between 2004 and 2014Original Research · 2017 · 128 citations
3Type II diabetes of early onset: a distinct clinical and genetic syndrome?Original Research · 1987 · 67 citations
4Association of Type 1 Diabetes vs Type 2 Diabetes Diagnosed During Childhood and Adolescence With Complications During Teenage Years and Young AdulthoodOriginal Research · 2017 · 697 citations
5Long-Term Complications and Mortality in Young-Onset DiabetesCohort Study · 2013 · 423 citations

Earlier Onset of Complications in Youth With Type 2 Diabetes2013
Prevalence of Diabetes Complications in Adolescents With Type 2 Compared With Type 1 Diabetes2006
Age at diagnosis, glycemic trajectories, and responses to oral glucose-lowering drugs in type 2 diabetes in Hong Kong: A population-based observational study2020
Empagliflozin in the treatment of heart failure with reduced ejection fraction in addition to background therapies and therapeutic combinations (EMPEROR-Reduced): a post-hoc analysis of a randomised, double-blind trialThe Lancet Diabetes & Endocrinology · 2021
Effects of dapagliflozin on major adverse kidney and cardiovascular events in patients with diabetic and non-diabetic chronic kidney disease: a prespecified analysis from the DAPA-CKD trialThe Lancet Diabetes & Endocrinology · 2020

More from The Lancet Diabetes & Endocrinology

More from University of Oxford

More from The University of Sydney

More from Sapienza University of Rome

More from Oxford Centre for Diabetes, Endocrinology and Metabolism